Effective Keloid Removal Treatment in Malaysia for Lasting Keloid Scar Control

No treatment offers guaranteed permanent keloid removal. Keloids result from a genetic predisposition to abnormal wound healing that persists throughout a patient's lifetime. What treatment achieves is significant flattening, reduction in size, symptom relief and the lowest achievable recurrence risk through combination therapy and ongoing maintenance. The 12.5 percent recurrence rate achievable with triple therapy (surgery plus injection plus silicone sheeting) is the lowest documented in published literature but still represents meaningful recurrence risk. At Nexus Clinic KL, patients are told this clearly before treatment begins, and a long-term management programme including 12-month post-treatment monitoring is part of every keloid care plan.

Keloid recurrence occurs because the treatment addresses the existing scar tissue but not the underlying predisposition of keloid-prone fibroblasts to overrespond to any new stimulus at the treated site. The inflammatory healing process at the treated area can itself trigger renewed fibroblast activation and collagen overproduction, especially if treatment ends abruptly without a post-treatment maintenance protocol. This is why steroid injection alone has a recurrence rate of 9 to 50 percent and surgery alone has a recurrence rate of 45 to 100 percent. The addition of silicone sheeting after treatment, the use of combination rather than single-modality therapy, and 12-month monitoring for early re-treatment are the strategies that collectively minimise long-term recurrence at Nexus Clinic KL.

Surgery alone is the worst treatment for keloids as a monotherapy, with published recurrence rates of 45 to 100 percent. Surgery creates a new wound at the same high-risk site, and in keloid-prone patients, this new wound can trigger a new and often larger keloid formation. When surgery is indicated for very large or resistant keloids that have failed a full injection and laser series, it must be combined with post-excision steroid injections administered immediately after closure and continued weekly for 2 to 5 weeks and then monthly for 3 to 6 months, silicone sheeting and potentially pressure therapy. This triple therapy reduces recurrence to approximately 12.5 percent. At Nexus Clinic KL, surgical excision for keloids is offered only within a planned combination protocol.

Intralesional steroid injections with triamcinolone acetonide are safe for Malaysian patients when performed correctly by trained doctors. The primary risk specific to darker Fitzpatrick skin types is hypopigmentation at the injection site, which is more visible in Malaysian Malay, Chinese and Indian patients than in lighter-skinned patients. At Nexus Clinic KL, this risk is managed through careful concentration calibration by site, conservative injection volumes per session and monitoring at every follow-up. For facial keloids where any pigmentation change would be highly visible, lower concentrations are used and laser is considered as a preferred primary modality.

The BCG vaccination given in early childhood is administered into the left upper deltoid and creates a deliberate skin wound. In keloid-prone patients, this wound can trigger keloid formation that begins months to years after vaccination. BCG keloids on the left upper arm are extremely common in Malaysian and Southeast Asian patients due to the near-universal childhood BCG vaccination programme and the elevated keloid predisposition in the Malaysian population. They typically present as a round or oval raised red or purplish nodule at the vaccination site that may have been slowly growing for years. BCG keloids respond well to the steroid injection series using the deltoid protocol and are among the more manageable keloid presentations at Nexus Clinic KL.

Most keloids require 3 to 6 injection sessions at 4 to 8 week intervals before optimal results are achieved. Smaller, early keloids may respond significantly within 3 sessions. Larger, older, or more fibrous keloids require the full 6 session course and sometimes more. The injection interval is important: too frequent sessions increase side effect risk without improving outcomes, while too infrequent sessions allow the keloid to partially re-expand between treatments. At Nexus Clinic KL, the interval is adjusted based on the keloid's response at each session. The first injection tends to produce the most noticeable initial softening.

Keloid treatment with steroid injection or cryotherapy can produce temporary changes at the treatment site. Hypopigmentation (lightening) is the most common visible side effect in darker Malaysian skin and typically fades over weeks to months. Skin atrophy (a slight depression) can occur with excessive triamcinolone concentration and is prevented through careful dosing at Nexus Clinic KL. The goal of treatment is a flat, softer, less symptomatic scar that is less visible than the active keloid. In most patients the treated site is significantly improved in appearance even accounting for any minor side effects from the treatment.

Earlobe keloids are among the most successfully manageable keloid presentations because the earlobe is low-tension skin with good blood supply. At Nexus Clinic KL, the first approach is always a series of 3 to 4 steroid injection sessions. If the keloid responds well but incompletely, injection sessions can be continued. If the keloid does not respond adequately, surgical excision of the earlobe keloid combined with immediate post-excision triamcinolone injection and wearing a pressure earring for 6 months afterwards produces very good outcomes with recurrence rates significantly lower than chest or shoulder keloids. Patients should not have earlobe keloids excised without a post-excision protocol planned, as excision alone still carries 50 to 80 percent recurrence risk.

Intralesional steroid injection into a keloid is uncomfortable rather than painful for most patients. The injection itself involves penetrating the dense, firm keloid tissue, which requires more pressure than a standard injection. At Nexus Clinic KL, lidocaine is routinely mixed with the triamcinolone to reduce pain during and immediately after the injection. The injection takes one to three minutes per keloid. Patients typically rate the discomfort as 3 to 5 out of 10 with lidocaine pretreatment. Cryotherapy produces a brief intense cold sensation that passes quickly. Laser treatment produces a warm snapping sensation managed with cooling. No keloid treatment at Nexus Clinic KL requires sedation.

The keloid assessment and treatment consultation at Nexus Clinic KL is included within the initial consultation fee. The consultation includes clinical assessment and measurement of the keloid, confirmation of diagnosis as true keloid versus hypertrophic scar, identification of the most appropriate treatment protocol based on site and size, full transparent pricing for the recommended treatment programme, realistic outcome expectations based on published recurrence data and written prevention guidance for future wounds. If your keloid has already been treated elsewhere and recurred, our doctors will review the previous treatment approach and explain what a different combination protocol could achieve.